During MS Awareness Month, a Groundbreaking Research-and-Care Model Looks Back on 20 Years of Firsts I am eager to see ...
Immunic Therapeutics was granted a patent in Europe that protects all dosing regimens of its MS therapy vidofludimus calcium ...
HOUSTON and WALTHAM, Mass., April 17, 2025 /PRNewswire/ -- Biostate AI, a leading innovator in artificial intelligence for RNA sequencing, today announced a strategic partnership with the Accelerated ...
Among adults with relapsing MS who received ublituximab, the annualized relapse rate continued to drop with up to 5 years of ...
Multiple sclerosis (MS) is a chronic disease of the central nervous system that causes disruptions in the flow of information within the brain and between the brain and body, eventually causing ...
Multiple sclerosis, or MS, is a disease that causes the immune system to attack the protective sheath that covers nerve fibers. Symptoms and severity of the disease vary from person to person. In some ...
MS is causing fewer deaths and less disability now than in years past, and the trend will likely continue in the coming years, a study found.
Christina Applegate says multiple sclerosis (MS) pain limits movement and keeps her largely bedridden, highlighting the disabling impact of the neurological disease.